| Drug Name | Arava (leflunomide) |
|---|---|
| Drug Class |
Immunosuppressant
|
| Risk minimization type |
Healthcare provider guide
|
| Specialty (Theraputic area) |
Rheumatology
|
| Risk |
Hepatotoxicity, hematotoxicity, infections, and serious birth defects when administered during pregnancy. |
| Health care provider guide |
|